Federal budget cuts have created "a climate of anxiety" among medical researchers, says Maximilian F. Konig, a rheumatologist ...

Deucravacitinib met its primary endpoint of more than 20% improvement in ACR20 response among patients with psoriatic ...

Arthritis awareness emphasizes early detection of arthritis, a condition affecting joints, bones, and muscles. Recognizing ...

Metabolic syndrome is common in psoriatic arthritis and is a known risk factor for worse symptoms and poor treatment outcomes. This study sought to explore the syndrome's role in a more precisely ...

Objective To evaluate the efficacy and safety of an oral selective tyrosine kinase 2 (TYK2) inhibitor, deucravacitinib, in patients with active psoriatic arthritis (PsA). Methods In this double-blind, ...

Psoriasis & Psoriatic Arthritis Treatments. Many drugs may treat skin and joints, but some perform better than others. According to the American College of Rheumatology and National Psoriasis ...

About 8 million Americans have psoriasis—up to 30% of people with psoriasis develop psoriatic arthritis. Psoriatic arthritis can be mild or severe, and it may involve one or many of your joints.

If you spend enough time sitting at your desk or slouching on the couch, your back will inevitably pay the price, regardless ...

Psoriatic disease is a long-term (chronic) disease with, thus far, no known cure. The good news, however, is that there are ...

Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with ...

Sudden joint pain, or arthralgia, can stem from various causes, ranging from viral infections like the flu and COVID-19 to ...

Former Emmerdale star Adam Thomas has been open about his health battles in recent years and now has told fans that his life ...